✦ LIBER ✦

695 SECRETORY LEUKOCYTE PROTEASE INHIBITOR ELEVATION A TARGET FOR HEPATITIS C INFECTION

✍ Scribed by M.W. Lawless; J.D. Ryan; K. Mclafferty; J. Crowe

Book ID: 117378780
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 47 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60697-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T1997 Secretory Leukocyte Protease Inhib

T1997 Secretory Leukocyte Protease Inhibitor Elevation a Target for Chronic Hepatitis C Infection

✍ Lawless, Matthew W.; Ryan, John D.; McLafferty, Karen; Crowe, John P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Telaprevir: An oral protease inhibitor f

Telaprevir: An oral protease inhibitor for hepatitis C virus infection

✍ Kim, J. J.; Culley, C. M.; Mohammad, R. A. 📂 Article 📅 2012 🏛 American Society of Health-System Pharmacists 🌐 English ⚖ 214 KB

Telaprevir: A Promising Protease Inhibit

Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

✍ Gentile, I.; Viola, C.; Borgia, F.; Castaldo, G.; Borgia, G. 📂 Article 📅 2009 🏛 Bentham Science Publishers 🌐 English ⚖ 220 KB

MK-5172: a second-generation protease in

MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection

✍ Gentile, Ivan; Buonomo, Antonio Riccardo; Borgia, Federico; Zappulo, Emanuela; C 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 311 KB

Protease inhibitors for treatment of chr

Protease inhibitors for treatment of chronic hepatitis C—a new target for the magic bullet identified

✍ Peter Ferenci 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Secretory leukocyte protease inhibitor:

Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein

✍ Nancy R Shine; Susan C Wang; Krystyna Konopka; Elizabeth A Burks; Nejat Düzgüneş 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 150 KB

The ability of the salivary protein, secretory leukocyte protease inhibitor (SLPI), to inhibit human immunodeficiency virus-1 (HIV-1) infection in vitro has been reported previously and has led to the suggestion that SLPI may be partially responsible for the low oral transmission rate of HIV-1. Howe